Akoya Biosciences, Inc.

General Information

We are an innovative life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. Our mission is to deliver a revolutionary new class of spatially derived biomarkers that empower life sciences researchers to better understand disease and clinicians to improve patient outcomes. Spatial biology refers to a rapidly evolving technology that enables academic and biopharma scientists to detect and map the distribution of cell types and biomarkers across whole tissue samples at single cell resolution, enabling advancements in their understanding of disease progression and patient response to therapy. Through our CODEX and Phenoptics platforms, reagents, software and services, we offer end-to-end solutions to perform tissue analysis and spatial phenotyping across the full continuum, from discovery through translational and clinical research.

Industry: Laboratory Analytical Instruments
Employees: 169
Founded: 2015
Contact Information
Address 100 Campus Drive, 6th Floor Marlborough, MA 01752
Phone Number (855) 896-8401
Web Address http://www.akoyabio.com/
View Prospectus: Akoya Biosciences, Inc.
Financial Information
Market Cap $678.11mil
Revenues $42.44 mil (last 12 months)
Net Income $-16.71 mil (last 12 months)
IPO Profile
Symbol AKYA
Exchange NASDAQ
Shares (millions): 6.6
Price range $20.00 - $20.00
Est. $ Volume $131.6 mil
Manager / Joint Managers J.P. Morgan/ Morgan Stanley/ Piper Sandler/ Canaccord Genuity
CO-Managers -
Expected To Trade: 4/16/2021
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change